Detransitioners reveal how doctors pushed them toward life-altering treatment as teens

Three detransitioners claim they were pressured by doctors and hospitals when they were young to pursue gender transition, including medical treatment in two cases while they were minors, according to a new HHS-commissioned report.

The stories of Clementine Breen, Soren Aldaco and Luke Healy were featured in the Department of Health and Human Services' "Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of "Gender Medicine" report released on Thursday. The HHS-commissioned report alleges financial incentives encouraged hospitals and doctors to provide gender transition treatments and identifies insurance billing practices that it says may be improper or warrant further investigation.

Breen was only 12 years old and struggling with a changing adolescent body and unresolved trauma from earlier sexual abuse when the then-minor learned about gender transition online. Breen alleges, according to the HHS report, that doctors at Childrens Hospital Los Angeles told Breens parents the preteen was "100% trans" and at high risk of suicide without medical intervention.

According to the report, Breen began puberty blockers at 12, testosterone at 13 and underwent a double mastectomy at 14.

HHS OFFICIAL WARNS OF IRREVERSIBLE RISKS AS TRUMP ADMIN RESTRICTS FUNDING FOR YOUTH GENDER PROCEDURES

Breens mental health later deteriorated, and the teen stopped taking testosterone at 18 after therapy led Breen to conclude that the distress surrounding gender identity was connected to earlier trauma, according to the report. Breen reported experiencing pain and irregular menstrual cycles and requiring estrogen.

When Breen later sought breast reconstruction, doctors questioned the teens mental stability, and some stopped responding, according to the report.

"She did not face this same scrutiny when seeking a mastectomy at 14," the report states. HHS also said Breen discovered letters in the medical record claiming a lifelong history of gender dysphoria.

Now studying theater at UCLA, Breen said in the report that the treatments and surgery continue to have physical consequences.

"How can a child consent to losing fertility or the ability to breastfeed if no one checks whether she even understand what that means?" Breen said.

Aldaco said gender-related distress emerged during adolescence and that online communities framed gender transition as the "appropriate response" to those feelings, according to the report.

After talking to a doctor, Aldaco was prescribed testosterone with several specialists treating the then-teen for gender dysphoria, and the report says Aldaco gave no indication that providers considered alternative treatment options outside what it calls a "sex rejection" model.

Aldaco began taking testosterone before receiving a double mastectomy to remove breast tissue. Aldaco then began suffering severe complications after surgery, causing pain the young person said "I dont think Ill ever forget."

"Despite these negative developments, providers did not initiate a structured reassessment of her treatment plan," the report says, adding that the support received after treatments was insufficient compared to the systems that pushed the life-altering decisions.

"Sorens experience reflects the imbalance of care for cases like hers," the report reads. "While her pathway into sex rejection medicalization involved coordinated referrals, approvals, and interventions across multiple providers, the pathway out involved no comparable system of sup